Skip to main content

New and competing renewal awards for May 2018

Monday, June 11, 2018
McGovern-Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of May 2018. Please extend your congratulations to the following individuals.

Yong-Hui Jiang (Medical Genetics) and Charles Gerbach (Biomedical Engineering) has received an award from Levo Therapeutics, Inc. in the amount of $1,719,885 for a project entitled” Developing Brain-penetrant G9a/GLP Inhibitors for Treating Prader-Willi Syndrome”.  The project period is 4/12/2018-04/11/2020.

Jennifer Rothman (Hematology-Oncology) has received an award from Agios Pharmaceutical in the amount of $62,496 for a project entitled “Pyruvate Kinase Deficiency Global Longitudinal Registry“.  The project period is 04/12/2018- 02/28/2026.

Raymond Barfield (Hematology-Oncology) and Margarita Bidegain (Neonatology) has received an award from Gundersen Lutheran Foundation in the amount of $10,260 for a project entitled “RTS Bereavement Training: Neonatal and Pediatric and Coordinator Training”.  The project period is 05/10/2018-12/31/2018.

Matthew Kelly (Infectious Diseases) has received an award from the National Institute of Health in the amount of $930,191 for a project entitled” Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants”.  The project period is 05/23/2018-04/30/2023.

Bradford Becken III (Infectious Diseases) has received an award from the Pediatric Scientist Development Program, Cincinnati Children’s Hospital Medical Center in the amount of $227,750 for a project entitled “The use of NExtGEn Genetics to Determine Gene Function in Genetically Intractable but Medically Important Microbes”.  The project period is 07/01/2018-06/30/2020.

Priya Kishnani (Medical Genetics) has received an award from Amicus Therapeutics in the amount of $482,287 for a project entitled “An Open-label, Ascending-Dose, First-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous Infusions of ATB2200 Alone and ATB200 Co-administered with Oral AT2221 in Adults”.  The project period is 05/09/2018 – 04/30/2019.

C. Michael Cotten (Neonatology) has received an award from Baebies Inc. in the amount of $68,414 for a project entitled “Comprehensive, Near Patient Assessment of Severe Hypoglycemia in Newborns Using Low Blood Volume (Phase II)”.  The project period is 05/01/2018- 04/30/2020.

Monica Lemmon (Neurology) has received an award from the Kennedy Krieger Institute (NIH-NINDS Child Neurology Career Development Program K-12) in the amount of $369,000 for a project entitled “Decision Making for Critically Ill Infants”.  The project period is 07/01/2018-06/30/2021.

Priya Kishnani (Medical Genetics) has received an award from Sanofi Work Order in the amount of $803,201 for a project entitled “An open-label ascending dose cohort study to assess the safety, pharmacokinetics, and preliminary efficacy of neoGAA (GZ402666) in patients with infantile-onset Pompe disease treated with alglucosidase alfa who demonstrate clinical decline”. The project period is 05/14/2018 – 12/31//2021.

P. Brian Smith (Neonatology) has received an award from the University of Arkansas for Medical Sciences/NIH in the amount of $1,050,783 for a project entitled” Data Coordinating and Operations Center for the IDeA States Pediatrics Clinical Trials Network”.  The project period is 09/01/2017-08/31/2020.

Laura Schanberg (Rheumatology) has received an award from Patient –Centered Outcomes Research Institute in the amount of $6,999,911 for a project entitled” Improving Outcomes in Limited Juvenile Idiopathic Arthritis.”  The project period is 07/01/2018-06/30/2023.

Daniel Benjamin (Infectious Diseases) has received an award from National Institute of Child Health and Human Development the amount of $96,000,000 for a project “entitled Best Pharmaceuticals for Children Act Pediatric Trials Network.”  The project period is 6/1/2018 – 05/31/2026.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health